Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasunori Aoki

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 5, 2023
A 20-Year Research Overview: Quantitative Prediction of Hepatic Clearance Using the In Vitro-In Vivo Extrapolation Approach Based on Physiologically Based Pharmacokinetic Modeling and Extended Clearance ConceptYuichi Sugiyama, Yasunori Aoki
CPT: Pharmacometrics & Systems Pharmacology|October 19, 2023
Cluster Gauss-Newton method for a quick approximation of profile likelihood: With application to physiologically-based pharmacokinetic modelsYasunori Aoki, Yuichi Sugiyama
Frontiers in Pharmacology|August 9, 2024
When to consider intra-target microdosing: physiologically based pharmacokinetic modeling approach to quantitatively identify key factors for observing target engagementYasunori Aoki, Malcom Rowland, Yuichi Sugiyama
The AAPS Journal|February 10, 2016
Preconditioning of Nonlinear Mixed Effects Models for Stabilisation of Variance-Covariance Matrix ComputationsYasunori Aoki, Rikard Nordgren, Andrew C Hooker
The AAPS Journal|December 9, 2025
Simultaneous Target-Mediated Drug Disposition-Pharmacodynamic (TMDD-PD) Modeling of Finasteride and Dutasteride: Impact of Target Binding and Turnover on Non-linear PharmacokineticsYuki Iwaki, Wooin Lee, Yasunori Aoki, et al.
Drug Safety|February 3, 2020
Disproportionality Analysis for Pharmacovigilance Signal Detection in Small Databases or Subsets: Recommendations for Limiting False-Positive AssociationsOla Caster, Yasunori Aoki, Lucie M Gattepaille, et al.
Computer Methods and Programs in Biomedicine|March 23, 2016
PopED lite: An optimal design software for preclinical pharmacokinetic and pharmacodynamic studiesYasunori Aoki, Monika Sundqvist, Andrew C Hooker, et al.
Journal of Pharmacokinetics and Pharmacodynamics|November 6, 2017
Model selection and averaging of nonlinear mixed-effect models for robust phase III dose selectionYasunori Aoki, Daniel Röshammar, Bengt Hamrén, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 9, 2021
Revisiting Nonlinear Bosentan Pharmacokinetics by Physiologically Based Pharmacokinetic Modeling: Target Binding, Albeit Not a Major Contributor to Nonlinearity, Can Offer Prediction of Target OccupancySatoshi Koyama, Kota Toshimoto, Wooin Lee, et al.
Clinical and Translational Science|November 27, 2024
Trends of in vitro pharmacological potency and in vivo pharmacokinetics parameters of modern drugs: Can the therapeutic/subtherapeutic dose be estimated from in vitro K<sub>i</sub> and pharmacokinetic parameters?Toshiaki Tsuchitani, Motohiro Kato, Atsuko Tomaru, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 5, 2023
A 20-Year Research Overview: Quantitative Prediction of Hepatic Clearance Using the In Vitro-In Vivo Extrapolation Approach Based on Physiologically Based Pharmacokinetic Modeling and Extended Clearance ConceptYuichi Sugiyama, Yasunori Aoki
CPT: Pharmacometrics & Systems Pharmacology|October 19, 2023
Cluster Gauss-Newton method for a quick approximation of profile likelihood: With application to physiologically-based pharmacokinetic modelsYasunori Aoki, Yuichi Sugiyama
Frontiers in Pharmacology|August 9, 2024
When to consider intra-target microdosing: physiologically based pharmacokinetic modeling approach to quantitatively identify key factors for observing target engagementYasunori Aoki, Malcom Rowland, Yuichi Sugiyama
The AAPS Journal|February 10, 2016
Preconditioning of Nonlinear Mixed Effects Models for Stabilisation of Variance-Covariance Matrix ComputationsYasunori Aoki, Rikard Nordgren, Andrew C Hooker
The AAPS Journal|December 9, 2025
Simultaneous Target-Mediated Drug Disposition-Pharmacodynamic (TMDD-PD) Modeling of Finasteride and Dutasteride: Impact of Target Binding and Turnover on Non-linear PharmacokineticsYuki Iwaki, Wooin Lee, Yasunori Aoki, et al.
Drug Safety|February 3, 2020
Disproportionality Analysis for Pharmacovigilance Signal Detection in Small Databases or Subsets: Recommendations for Limiting False-Positive AssociationsOla Caster, Yasunori Aoki, Lucie M Gattepaille, et al.
Computer Methods and Programs in Biomedicine|March 23, 2016
PopED lite: An optimal design software for preclinical pharmacokinetic and pharmacodynamic studiesYasunori Aoki, Monika Sundqvist, Andrew C Hooker, et al.
Journal of Pharmacokinetics and Pharmacodynamics|November 6, 2017
Model selection and averaging of nonlinear mixed-effect models for robust phase III dose selectionYasunori Aoki, Daniel Röshammar, Bengt Hamrén, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 9, 2021
Revisiting Nonlinear Bosentan Pharmacokinetics by Physiologically Based Pharmacokinetic Modeling: Target Binding, Albeit Not a Major Contributor to Nonlinearity, Can Offer Prediction of Target OccupancySatoshi Koyama, Kota Toshimoto, Wooin Lee, et al.
Clinical and Translational Science|November 27, 2024
Trends of in vitro pharmacological potency and in vivo pharmacokinetics parameters of modern drugs: Can the therapeutic/subtherapeutic dose be estimated from in vitro K<sub>i</sub> and pharmacokinetic parameters?Toshiaki Tsuchitani, Motohiro Kato, Atsuko Tomaru, et al.
Pageof 6